| #58 |
Hans Schambye |
Galecto Biotech Ab |
1 |
| #58 |
Joachim Harteg Jacobsen |
Haldor Topsøe A/S |
1 |
| #58 |
Jan Lehmbeck |
Novozymes A/S |
1 |
| #58 |
Martijn Beukema |
Dow Silicones |
1 |
| #58 |
Tilo Schwientek |
Glycozym Aps |
1 |
| #58 |
Jens Breinholt |
Novo Nordisk A/S |
1 |
| #58 |
Julia Sidenius Johansen |
University of California |
1 |
| #58 |
Claus Crone Fuglsang |
Novo Nordisk A/S |
1 |
| #58 |
Jakob Wedel-Heinen |
Nkt Flexibles I/S |
1 |
| #58 |
Jørgen Smedegaard |
Novo Nordisk A/S |
1 |
| #58 |
Claus Aage Svensgaard Bretting |
Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) |
1 |
| #58 |
Walter Florio |
Statens Serum Institut |
1 |
| #58 |
Soren Tullin |
— |
1 |
| #58 |
Hans Schambye |
— |
1 |
| #58 |
Lise Ostergaard Brandt |
Statens Serum Institut |
1 |
| #58 |
Konrad Herbst |
Haldor Topsøe A/S |
1 |
| #58 |
Helle Kayerød |
Coloplast A/S |
1 |
| #58 |
Svend-Erik Mikkelsen |
Haldor Topsøe A/S |
1 |
| #58 |
Henrik Pfundheller |
Exiqon A/S |
1 |
| #58 |
Carsten Fallesen |
Epcos Ag |
1 |
| #58 |
Kim Steengaard |
Novo Nordisk A/S |
1 |
| #58 |
Eugene Lukanidin |
Research Corporation Technologies |
1 |
| #58 |
Mogens Jakobsen |
Exiqon A/S |
1 |
| #58 |
Carl Ludvigsen |
Widex A/S |
1 |
| #58 |
Peter Andersen |
Statens Serum Institut |
1 |
| #58 |
Søren Christensen |
Bang & Olufsen A/S |
1 |
| #58 |
Liselotte Bjerre Knudsen |
Novo Nordisk A/S |
1 |